Cargando…
Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells
Autores principales: | Charo, Jehad, Gomes, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319331/ https://www.ncbi.nlm.nih.gov/pubmed/34321457 http://dx.doi.org/10.1038/s41392-021-00706-0 |
Ejemplares similares
-
CAR T cells remain during long-term cancer remission
por: Barnes, Katharine
Publicado: (2022) -
Antigen targeting to dendritic cells: Still a place in future immunotherapy?
por: Stoitzner, Patrizia, et al.
Publicado: (2022) -
High hopes and high honours for cancer immunotherapy
por: Häfner, Sophia Julia
Publicado: (2019) -
Constant regulation for stable CD8 T‐cell functional avidity and its possible implications for cancer immunotherapy
por: Gilfillan, Connie B., et al.
Publicado: (2021) -
Step further towards targeted senolytic therapy: therapeutic potential of uPAR-CAR T cells for senescence-related diseases
por: Huang, Yujia, et al.
Publicado: (2020)